Drugs / Vitamin B1-6-12
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07708233 Comparator | Jul 2026 → Jun 2027 expected | diabetic polyneuropathy | Thammasat University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitamin B1-6-12 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07708233 ↗ |
| Route | Oral | “65 mcg per tablet) orally twice daily” NCT07708233 ↗ |